209 related articles for article (PubMed ID: 32321781)
1. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
Lipsett SC; Branda JA; Nigrovic LE
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
[TBL] [Abstract][Full Text] [Related]
6. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
Sabin AP; Scholze BP; Lovrich SD; Callister SM
Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542
[TBL] [Abstract][Full Text] [Related]
8. Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context.
Can Commun Dis Rep; 2020 May; 46(5):125-131. PubMed ID: 32558809
[TBL] [Abstract][Full Text] [Related]
9. Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.
Molins CR; Delorey MJ; Sexton C; Schriefer ME
J Clin Microbiol; 2016 Nov; 54(11):2726-2734. PubMed ID: 27558183
[TBL] [Abstract][Full Text] [Related]
10. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.
Lipsett SC; Branda JA; McAdam AJ; Vernacchio L; Gordon CD; Gordon CR; Nigrovic LE
Clin Infect Dis; 2016 Oct; 63(7):922-8. PubMed ID: 27358358
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Testing for Lyme Disease.
Kobayashi T; Auwaerter PG
Infect Dis Clin North Am; 2022 Sep; 36(3):605-620. PubMed ID: 36116838
[TBL] [Abstract][Full Text] [Related]
17. Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
Porwancher R; Landsberg L
PLoS One; 2021; 16(9):e0253514. PubMed ID: 34499659
[TBL] [Abstract][Full Text] [Related]
18. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers.
Marques AR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
